Your browser doesn't support javascript.
loading
Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.
Erhart, Friedrich; Weiss, Tamara; Klingenbrunner, Simone; Fischhuber, Katrin; Reitermaier, René; Halfmann, Angela; Blauensteiner, Bernadette; Lötsch, Daniela; Spiegl-Kreinecker, Sabine; Berger, Walter; Sialana, Fernando J; Lubec, Gert; Felzmann, Thomas; Dohnal, Alexander; Visus, Carmen.
Afiliación
  • Erhart F; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria; Institute of Neurology, Medical University of Vienna, Vienna, Austria; Department of Tumor Immunology, St. Anna Kinderkrebsforschung Children's Cancer Research Institute, Vienna, Austria.
  • Weiss T; Department of Tumor Biology, St. Anna Kinderkrebsforschung Children's Cancer Research Institute, Vienna, Austria.
  • Klingenbrunner S; Activartis Biotech GmbH, Vienna, Austria.
  • Fischhuber K; Activartis Biotech GmbH, Vienna, Austria.
  • Reitermaier R; Activartis Biotech GmbH, Vienna, Austria.
  • Halfmann A; Department of Tumor Immunology, St. Anna Kinderkrebsforschung Children's Cancer Research Institute, Vienna, Austria.
  • Blauensteiner B; Department of Tumor Immunology, St. Anna Kinderkrebsforschung Children's Cancer Research Institute, Vienna, Austria.
  • Lötsch D; Institute for Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Spiegl-Kreinecker S; University Clinic for Neurosurgery, Kepler University Hospital, Johannes Kepler University, Linz, Austria.
  • Berger W; Institute for Cancer Research, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Sialana FJ; Division of Drug Design and Medicinal Chemistry, Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria.
  • Lubec G; Division of Drug Design and Medicinal Chemistry, Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria.
  • Felzmann T; Research & Development, Central Blood Bank, Austrian Red Cross, Vienna, Austria; Activartis Biotech GmbH, Vienna, Austria.
  • Dohnal A; Department of Tumor Immunology, St. Anna Kinderkrebsforschung Children's Cancer Research Institute, Vienna, Austria. Electronic address: alexander.dohnal@gmx.at.
  • Visus C; Activartis Biotech GmbH, Vienna, Austria.
Cytotherapy ; 21(6): 643-658, 2019 06.
Article en En | MEDLINE | ID: mdl-30975602
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Neoplasias Encefálicas / Glioblastoma / Técnicas de Cultivo de Célula / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2019 Tipo del documento: Article País de afiliación: Austria
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Neoplasias Encefálicas / Glioblastoma / Técnicas de Cultivo de Célula / Proteínas de Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2019 Tipo del documento: Article País de afiliación: Austria